StonvexLoading…
StonvexCore line items from DBRG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $374.45M | $329.69M | $264.12M | $172.67M |
Operating Income | $-17.03M | $168.81M | $365.63M | $-46.68M |
Net Income | $141.87M | $70.52M | $185.28M | $-321.80M |
EPS (Diluted) | $0.46 | $0.07 | $0.77 | $-2.47 |
Total Assets | $3.42B | $3.51B | $3.56B | $11.03B |
Total Liabilities | $968.96M | $1.02B | $1.05B | $6.46B |
Cash & Equivalents | $382.51M | $302.15M | $345.33M | $855.56M |
Free Cash Flow OCF − CapEx | $257.98M | $56.53M | $233.64M | $262.58M |
Shares Outstanding | 175.73M | 168.82M | 169.72M | 154.50M |